Samrat Pharmachem share news and announcements

BSE: 530125Pharmaceuticals & BiotechnologySmall Cap

₹277.50₹10.60 (3.68%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹288.10.

52-week range of traded prices to 23 Oct 2026

₹190.00Low, 30 Mar 2026₹309.85High, 30 Oct 2025

Next results date: the board meets on 14 Nov 2026 to consider: quarterly results.

Market cap: ₹86 Cr3,210th largest listed
P/E: Lossover the last 12 months
P/B: 1.3
Dividend yield: Nonein the last 12 months
ROE: −3.2%
ROCE: −2.7%
Debt to equity: 0.16
Volume, BSE: 1,601

Samrat Pharmachem board meetings

92 filed, newest first. Page 1 of 2.

Sep 2026
- 28 Sep · Board meeting
  Meeting on 14 Nov 2026: quarterly results
- 26 Sep · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Samrat Pharmachem Limited .... (opens in a new tab)
Jun 2026
- 30 Jun · Board meeting
  Meeting on 14 Aug 2026: quarterly results
- 30 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Approval of Un-Audited Financial .... (opens in a new tab)
Mar 2026
- 25 Mar · Board meeting
  Meeting on 30 May 2026: audited results
- 25 Mar · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results .... (opens in a new tab)
Dec 2025
- 29 Dec · Board meeting
  Meeting on 13 Feb 2026: quarterly results
- 29 Dec · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial .... (opens in a new tab)
Sep 2025
- 26 Sep · Board meeting
  Meeting on 14 Nov 2025: quarterly results
- 26 Sep · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-audited financial .... (opens in a new tab)
Jun 2025
- 24 Jun · Board meeting
  Meeting on 13 Aug 2025: quarterly results
- 23 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the un-audited financial .... (opens in a new tab)
May 2025
- 30 May · Board meeting
  Outcome of Board Meeting held today (opens in a new tab)
Mar 2025
- 26 Mar · Board meeting
  Meeting on 30 May 2025: audited results and final dividend
- 26 Mar · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Standalone Financial .... (opens in a new tab)
Dec 2024
- 31 Dec · Board meeting
  Meeting on 14 Feb 2025: quarterly results
- 31 Dec · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the Un-audited financial .... (opens in a new tab)
Sep 2024
- 27 Sep · Board meeting
  Meeting on 14 Nov 2024: quarterly results
- 27 Sep · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
Aug 2024
- 13 Aug · Board meeting
  Board has considered and took on record the Un-audited Financial Results for the quarter ended June 30, 2024. (opens in a new tab)
Jul 2024
- 1 Jul · Board meeting
  Meeting on 13 Aug 2024: quarterly results
Jun 2024
- 29 Jun · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
May 2024
- 30 May · Board meeting
  Board of Directors approved and adopted Audited Financial Results for the quarter and year ended March 31, 2024. Recommendation of Dividend @ 10% on paid up capital of the company (opens in a new tab)
Mar 2024
- 28 Mar · Board meeting
  Meeting on 30 May 2024: audited results and final dividend
- 28 Mar · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the Audited Standalone .... (opens in a new tab)
Feb 2024
- 14 Feb · Board meeting
  Board has considered and took on record the Un-Audited Standalone Financial Results of the Company for the quarter ended December 31, 2023. (opens in a new tab)
Dec 2023
- 29 Dec · Board meeting
  Meeting on 14 Feb 2024: quarterly results
- 29 Dec · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Nov 2023
- 8 Nov · Board meeting
  Approval of Results for the quarter and half year ended September 30, 2023 (opens in a new tab)
Sep 2023
- 26 Sep · Board meeting
  Meeting on 8 Nov 2023: quarterly results
- 26 Sep · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve the un-audited standalone .... (opens in a new tab)
Jun 2023
- 30 Jun · Board meeting
  Meeting on 14 Aug 2023: quarterly results
- 30 Jun · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
Mar 2023
- 28 Mar · Board meeting
  Meeting on 30 May 2023: dividend and audited results
- 28 Mar · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Standalone .... (opens in a new tab)
- 16 Mar · Board meeting
  We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday, March 16, 2023, has appointed the following Directors on the recommendation of .... (opens in a new tab)
- 1 Mar · Board meeting
  Meeting on 16 Mar 2023
- 1 Mar · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2023 ,inter alia, to consider and approve re-appointment of 3 Executive .... (opens in a new tab)
Feb 2023
- 14 Feb · Board meeting
  We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Tuesday, February 14, 2023, the Board has considered and took on record the attached Un-Audited .... (opens in a new tab)
Dec 2022
- 29 Dec · Board meeting
  Meeting on 14 Feb 2023: quarterly results
- 29 Dec · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Nov 2022
- 14 Nov · Board meeting
  We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, November 14, 2022, the Board has considered and took on record the Un-Audited Standalone .... (opens in a new tab)
Sep 2022
- 30 Sep · Board meeting
  Meeting on 14 Nov 2022: quarterly results
- 30 Sep · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Aug 2022
- 13 Aug · Board meeting
  We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, August 13, 2022, the Board has considered and took on record the attached Un-Audited .... (opens in a new tab)
Jun 2022
- 30 Jun · Board meeting
  Meeting on 13 Aug 2022: quarterly results
- 30 Jun · Board meeting
  SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
May 2022
- 30 May · Board meeting
  Approval of Audited Financial Results of the Company for the year ended March 31, 2022 Recommendation of Dividend @ 10% on Subscribed Capital of the company Fixing of Date of AGM .... (opens in a new tab)
- 30 May · Board meeting
  We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, May 30, 2022, the Board has considered and adopted the attached Audited Financial Results .... (opens in a new tab)
Apr 2022
- 7 Apr · Board meeting
  Meeting of the Board of Directors of the Company will be held on May 30, 2022, inter alia, to consider, approve and take on record the Audited .... (opens in a new tab)

Samrat Pharmachem board meetings

Sep 2026

Jun 2026

Mar 2026

Dec 2025

Sep 2025

Jun 2025

May 2025

Mar 2025

Dec 2024

Sep 2024

Aug 2024

Jul 2024

Jun 2024

May 2024

Mar 2024

Feb 2024

Dec 2023

Nov 2023

Sep 2023

Jun 2023

Mar 2023

Feb 2023

Dec 2022

Nov 2022

Sep 2022

Aug 2022

Jun 2022

May 2022

Apr 2022